Aprea Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Aprea Therapeutics, Inc. (APRE) reported Foreign Currency Transaction Gain (Loss), before Tax of $2.95 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-12
- Aprea Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $2.95K.
- Aprea Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $7.71K.
- Aprea Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$8.70K, a 115.37% decline year-over-year.
- Aprea Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$5.69K.
- Aprea Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$95.32K, a 232.76% decline from fiscal 2024.
- Aprea Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was $71.80K.
- Aprea Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$38.93K, a 113.83% decline from fiscal 2022.
- Aprea Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was $281.53K, a 11.30% decline from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.95K 10-Q · filed 2026-08-12 | $10.66K 10-Q · filed 2026-08-12 | $1.96K derived: sum of 3 quarters · filed 2026-08-12 | -$3.73K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $7.71K 10-Q · filed 2026-05-13 | -$990.00 derived: sum of 2 quarters · filed 2026-05-13 | -$6.68K derived: sum of 3 quarters · filed 2026-05-13 | -$35.80K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$8.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$14.39K derived: sum of 2 quarters · filed 2026-03-16 | -$43.52K derived: sum of 3 quarters · filed 2026-08-12 | -$95.32K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$5.69K 10-Q · filed 2025-11-12 | -$34.81K derived: sum of 2 quarters · filed 2026-08-12 | -$86.62K 10-Q · filed 2025-11-12 | -$30.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$29.12K 10-Q · filed 2026-08-12 | -$80.93K 10-Q · filed 2026-08-12 | -$24.31K derived: sum of 3 quarters · filed 2026-08-12 | -$59.80K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$51.80K 10-Q · filed 2026-05-13 | $4.82K derived: sum of 2 quarters · filed 2026-05-13 | -$30.68K derived: sum of 3 quarters · filed 2026-05-13 | -$36.18K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $56.62K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $21.13K derived: sum of 2 quarters · filed 2026-03-16 | $15.62K derived: sum of 3 quarters · filed 2026-03-16 | $71.80K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$35.49K 10-Q · filed 2025-11-12 | -$41.00K derived: sum of 2 quarters · filed 2025-11-12 | $15.18K 10-Q · filed 2025-11-12 | -$63.43K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$5.50K 10-Q · filed 2025-08-12 | $50.67K 10-Q · filed 2025-08-12 | -$27.94K derived: sum of 3 quarters · filed 2025-08-12 | -$30.82K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $56.18K 10-Q · filed 2025-05-14 | -$22.44K derived: sum of 2 quarters · filed 2025-05-14 | -$25.32K derived: sum of 3 quarters · filed 2025-05-14 | $31.05K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$78.61K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$81.49K derived: sum of 2 quarters · filed 2025-03-25 | -$25.13K derived: sum of 3 quarters · filed 2025-03-25 | -$38.93K 10-K · filed 2025-03-25 |
| 2023-09-30 | -$2.88K 10-Q · filed 2024-11-07 | $53.48K derived: sum of 2 quarters · filed 2024-11-07 | $39.69K 10-Q · filed 2024-11-07 | $6.09K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $56.36K 10-Q · filed 2024-08-12 | $42.57K 10-Q · filed 2024-08-12 | $8.97K derived: sum of 3 quarters · filed 2024-08-12 | $33.32K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$13.80K 10-Q · filed 2024-05-14 | -$47.39K derived: sum of 2 quarters · filed 2024-05-14 | -$23.04K derived: sum of 3 quarters · filed 2024-05-14 | $131.53K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$33.60K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$9.24K derived: sum of 2 quarters · filed 2024-03-26 | $145.32K derived: sum of 3 quarters · filed 2024-03-26 | $281.53K 10-K · filed 2024-03-26 |
| 2022-09-30 | $24.35K 10-Q · filed 2023-11-09 | $178.92K derived: sum of 2 quarters · filed 2023-11-09 | $315.13K 10-Q · filed 2023-11-09 | $385.30K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | $154.57K 10-Q · filed 2023-08-10 | $290.78K 10-Q · filed 2023-08-10 | $360.95K derived: sum of 3 quarters · filed 2024-03-26 | $339.04K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-03-31 | $136.21K 10-Q · filed 2023-05-15 | $206.38K derived: sum of 2 quarters · filed 2024-03-26 | $184.47K derived: sum of 3 quarters · filed 2024-03-26 | -$68.37K derived: sum of 4 quarters · filed 2024-03-26 |
| 2021-12-31 | $70.17K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $48.26K derived: sum of 2 quarters · filed 2024-03-26 | -$204.58K derived: sum of 3 quarters · filed 2024-03-26 | $317.40K 10-K · filed 2024-03-26 |
| 2021-09-30 | -$21.91K 10-Q · filed 2022-11-09 | -$274.75K derived: sum of 2 quarters · filed 2022-11-09 | $247.23K 10-Q · filed 2022-11-09 | -$926.65K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-06-30 | -$252.84K 10-Q · filed 2022-08-12 | $269.14K 10-Q · filed 2022-08-12 | -$904.75K derived: sum of 3 quarters · filed 2023-03-30 | -$979.31K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-03-31 | $521.98K 10-Q · filed 2022-05-16 | -$651.90K derived: sum of 2 quarters · filed 2023-03-30 | -$726.47K derived: sum of 3 quarters · filed 2023-03-30 | -$2.62M derived: sum of 4 quarters · filed 2023-03-30 |
| 2020-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.25M derived: sum of 2 quarters · filed 2023-03-30 | -$3.14M derived: sum of 3 quarters · filed 2023-03-30 | -$890.25K 10-K · filed 2023-03-30 |
| 2020-09-30 | -$74.56K 10-Q · filed 2021-11-08 | -$1.96M derived: sum of 2 quarters · filed 2021-11-08 | $283.64K 10-Q · filed 2021-11-08 | -$979.23K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$1.89M 10-Q · filed 2021-08-12 | $358.20K 10-Q · filed 2021-08-12 | -$904.67K derived: sum of 3 quarters · filed 2022-03-15 | $70.37K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $2.25M 10-Q · filed 2021-05-06 | $985.02K derived: sum of 2 quarters · filed 2022-03-15 | $1.96M derived: sum of 3 quarters · filed 2022-03-15 | $2.64M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$287.83K derived: sum of 2 quarters · filed 2022-03-15 | $392.22K derived: sum of 3 quarters · filed 2022-03-15 | $1.33M 10-K · filed 2022-03-15 |
| 2019-09-30 | $975.03K 10-Q · filed 2020-11-06 | $1.66M derived: sum of 2 quarters · filed 2020-11-06 | $2.59M 10-Q · filed 2020-11-06 | $2.81M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $680.06K 10-Q · filed 2020-08-11 | $1.62M 10-Q · filed 2020-08-11 | $1.84M derived: sum of 3 quarters · filed 2021-03-16 | $1.63M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $935.92K 10-Q · filed 2020-05-15 | $1.16M derived: sum of 2 quarters · filed 2021-03-16 | $948.07K derived: sum of 3 quarters · filed 2021-03-16 | |
| 2018-12-31 | $219.70K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $12.16K derived: sum of 2 quarters · filed 2021-03-16 | $961.32K 10-K · filed 2021-03-16 | |
| 2018-09-30 | -$207.54K 10-Q · filed 2019-11-14 | $741.62K 10-Q · filed 2019-11-14 | ||
| 2017-12-31 | $662.14K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |